2WN-17142-91687
3 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 751 / TX
- Registered
- 2021-10-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-10-09
Registered in v-safe
-
2021-10-09
Dose 3 — Pfizer-BioNTech
- 2021-10-09
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-11
-
2021-10-12
Survey response — days 1–6 daily, dose 3MedDRA: Aura — Feeling: GoodFree text: AuraMedDRA releases: 2024-11 · check-in free text available
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2022-01-08
- 2022-04-09
- 2022-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | No |
| 2 | 2021-01-20 | Pfizer-BioNTech | No |
| 3 | 2021-10-09 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Aura
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Aura | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release